Cargando…
Successful Anti-SARS-CoV-2 Spike Protein Antibody Response to Vaccination in MAGT1 Deficiency
BACKGROUND: Novel messenger RNA vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV-2) have been vital in resolving the coronavirus disease-2019 (COVID-19) pandemic. Detection of neutralizing antibodies (NAbs) against the SARS-CoV-2 spike protein (S) confirms immunogenicity with...
Autores principales: | Jalil, Maaz, Rowane, Marija, Rajan, Jayanth, Hostoffer, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640323/ https://www.ncbi.nlm.nih.gov/pubmed/34868726 http://dx.doi.org/10.1177/21526567211056239 |
Ejemplares similares
-
CD5 B-Cell Predominant Primary Immunodeficiency: Part of the Spectrum of MAGT1 Deficiency
por: Rowane, Marija J., et al.
Publicado: (2023) -
The Successful Vaccination of an IVIgG Naive CVID Patient with an mRNA COVID-19 Vaccine
por: Jalil, Maaz, et al.
Publicado: (2021) -
Radiologic Contrast Media Desensitization for Delayed Cardiac Catheterization
por: Sanan, Neha, et al.
Publicado: (2019) -
Familial Success in Allergen Desensitization
por: Rowane, Marija, et al.
Publicado: (2019) -
Expedited Desensitization to Canakinumab
por: Sanan, Neha, et al.
Publicado: (2020)